| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000232940.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.039516358 |
Resistant |
| ENSG00000232940.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.020202917 |
Sensitive |
| ENSG00000232940.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.034708431 |
Sensitive |
